@article {Hiramatsu:May 2004:1462-8902:231, author = "Hiramatsu, S.", author = "Tajiri, Y.", author = "Karashima, T.", title = "Lower plasma adiponectin concentration predicts the efficacy of pioglitazone in diabetic patients", journal = "Diabetes, Obesity and Metabolism", volume = "6", year = "May 2004", abstract = "Aim: 

To investigate clinical efficacy of pioglitazone in association with plasma adiponectin concentration in type 2 diabetic patients. Methods: 

Ten diabetic patients were treated with 15 or 30 mg of pioglitazone for 8 weeks, and association between plasma adiponectin concentration before treatment and decrease in glycated albumin levels was examined. Results: 

Treatment with pioglitazone for 8 weeks lowered glycated albumin level (27.1 ± 1.2 to 23.8 ± 1.4%, p < 0.05), and inverse relationship between changes in glycated albumin and plasma adiponectin concentration before treatment was revealed (r = −0.66, p < 0.05). Plasma adiponectin concentrations of patients whose glycated albumin level reduced by more than 10% of the levels before treatment were significantly lower than those of patients whose glycaemic control was affected less (5.2 ± 0.6 vs. 8.0 ± 1.0 µg/ml, p < 0.05). Conclusion: 

Lower plasma adiponectin concentration predicts the clinical efficacy of pioglitazone.", pages = "231-233(3)", url = "http://www.ingentaconnect.com/content/bsc/dom/2004/00000006/00000003/art00010" doi = "doi:10.1111/j.1462-8902.2004.00333.x" }